Community-acquired pneumonia: How far have we come? Gerald R. Donowitz Invited Commentary Pages: 419 - 420
Adjunctive immunotherapy in combination with lipid-associated amphotericin B for the treatment of invasive candidiasis Stanley W. Chapman Clinical Trials Report Pages: 425 - 426
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia Jack D. Sobel OriginalPaper Pages: 427 - 433
Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient Arlo UptonKieren A. Marr OriginalPaper Pages: 434 - 441
The role of echinocandins, extended-spectrum azoles, and polyenes to treat opportunistic moulds and candida Thomas F. Patterson OriginalPaper Pages: 442 - 448
Recent insights into the mechanisms of antifungal resistance Katherine S. BarkerP. David Rogers OriginalPaper Pages: 449 - 456
Stress, bacterial vaginosis, and the role of immune processes Jennifer F. CulhaneVirginia A. RauhRobert L. Goldenberg OriginalPaper Pages: 459 - 464
Urinary tract infection in women: New pathogenic considerations Ann E. Stapleton OriginalPaper Pages: 465 - 472
Management of recurrent vulvovaginal candidiasis: Unresolved issues Jack D. Sobel OriginalPaper Pages: 481 - 486
Metabolic abnormalities in HIV-infected patients: An update Todd T. BrownJoseph Cofrancesco Jr OriginalPaper Pages: 497 - 504